Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$88.02 - $127.79 $2.48 Million - $3.6 Million
-28,201 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$122.75 - $162.68 $223,282 - $295,914
-1,819 Reduced 6.06%
28,201 $3.63 Million
Q2 2021

Aug 16, 2021

SELL
$105.76 - $154.96 $136,007 - $199,278
-1,286 Reduced 4.11%
30,020 $4.58 Million
Q1 2021

May 17, 2021

SELL
$78.5 - $126.48 $36,110 - $58,180
-460 Reduced 1.45%
31,306 $3.3 Million
Q4 2020

Feb 16, 2021

SELL
$55.93 - $82.78 $40,045 - $59,270
-716 Reduced 2.2%
31,766 $2.52 Million
Q3 2020

Nov 13, 2020

SELL
$45.65 - $61.81 $1.24 Million - $1.68 Million
-27,202 Reduced 45.58%
32,482 $1.84 Million
Q2 2020

Aug 14, 2020

BUY
$29.15 - $61.54 $1.74 Million - $3.67 Million
59,684 New
59,684 $3.67 Million
Q4 2019

Feb 14, 2020

SELL
$24.55 - $38.13 $883,800 - $1.37 Million
-36,000 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$25.78 - $34.8 $438,260 - $591,600
-17,000 Reduced 32.08%
36,000 $928,000
Q2 2019

Aug 14, 2019

SELL
$23.08 - $37.01 $994,955 - $1.6 Million
-43,109 Reduced 44.85%
53,000 $1.56 Million
Q1 2019

May 14, 2019

BUY
$27.81 - $40.78 $164,607 - $241,376
5,919 Added 6.56%
96,109 $3.29 Million
Q4 2018

Feb 14, 2019

BUY
$28.91 - $50.0 $977,042 - $1.69 Million
33,796 Added 59.93%
90,190 $2.88 Million
Q3 2018

Nov 14, 2018

BUY
$30.85 - $50.65 $706,279 - $1.16 Million
22,894 Added 68.34%
56,394 $2.71 Million
Q2 2018

Jul 19, 2018

BUY
$13.95 - $32.65 $467,325 - $1.09 Million
33,500 New
33,500 $1.04 Million

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.15B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.